Roberto Muga Selected Research

Roberto Muga Research Topics

Disease

17	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 10/2002
11	Substance-Related Disorders (Drug Abuse) 05/2022 - 05/2004
9	Infections 01/2019 - 10/2002
8	HIV Infections (HIV Infection) 01/2019 - 12/2003
6	HIV Seropositivity 01/2019 - 10/2002
5	Hepatitis C 01/2019 - 05/2004
4	Alcoholism (Alcohol Abuse) 01/2021 - 01/2018
3	Coinfection 01/2019 - 01/2008
2	Mental Disorders (Mental Disorder) 05/2022 - 01/2021
2	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 01/2021
2	Cocaine-Related Disorders (Cocaine Addiction) 01/2021 - 05/2004
2	Neoplasms (Cancer) 01/2021 - 03/2014
2	Liver Diseases (Liver Disease) 06/2015 - 04/2013
2	Chronic Hepatitis C 10/2013 - 01/2008
2	Disease Progression 12/2011 - 09/2008
1	Seizures (Absence Seizure) 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Poisoning 01/2021
1	Hyperuricemia 11/2020
1	Pathologic Processes 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Abdominal Obesity 01/2018
1	Overweight 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Obesity 01/2018
1	AIDS Dementia Complex 01/2018
1	Hypertriglyceridemia 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	End Stage Liver Disease 01/2018
1	Viremia 02/2017
1	Virus Diseases (Viral Diseases) 09/2014
1	Opportunistic Infections (Opportunistic Infection) 03/2014
1	Bacterial Infections (Bacterial Infection) 03/2014
1	Fibrosis (Cirrhosis) 10/2013
1	Torsades de Pointes (Torsade de Pointes) 10/2013
1	Heart Diseases (Heart Disease) 10/2013
1	Hepatitis 04/2013
1	Hemophilia A (Haemophilia) 04/2013
1	Blood-Borne Infections 01/2008
1	Tuberculosis (Tuberculoses) 11/2007
1	Chronic Disease (Chronic Diseases) 05/2004

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2021 - 12/2003
4	Heroin (Diamorphine)IBA 01/2022 - 05/2004
4	Methadone (Dolophine)FDA LinkGeneric 01/2021 - 05/2004
4	RNA (Ribonucleic Acid)IBA 01/2019 - 03/2014
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 08/2007
3	Cocaine (Cocaine HCl)IBA 05/2022 - 04/2020
3	Opioid Analgesics (Opioids)IBA 01/2022 - 10/2013
3	efavirenz (Sustiva)FDA Link 01/2018 - 08/2012
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2018 - 04/2015
2	Viral RNAIBA 01/2019 - 03/2014
2	Antiviral Agents (Antivirals)IBA 01/2018 - 06/2015
2	Lopinavir FDA Link 01/2018 - 04/2015
1	Amino Acids FDA Link 05/2022
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	TransferasesIBA 11/2020
1	HDL CholesterolIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	Darunavir (Prezista)FDA Link 01/2018
1	CholesterolIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	HDL LipoproteinsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 06/2015
1	InterferonsIBA 06/2015
1	ElectrolytesIBA 10/2013
1	Nevirapine (Viramune)FDA Link 08/2012
1	NucleosidesIBA 08/2012
1	Reverse Transcriptase InhibitorsIBA 08/2012
1	BilirubinIBA 01/2012
1	Serum AlbuminIBA 01/2012
1	EnzymesIBA 01/2008
1	Transaminases (Aminotransferases)IBA 01/2008

Therapy/Procedure

14	Therapeutics 01/2018 - 10/2002
8	Highly Active Antiretroviral Therapy (HAART) 01/2019 - 01/2006
3	Art Therapy 01/2019 - 10/2013
3	First Aid (Aids, First) 03/2011 - 10/2002
1	Secondary Prevention 01/2018
1	Aftercare (After-Treatment) 02/2017
1	Opiate Substitution Treatment 09/2014
1	Duration of Therapy 01/2014
1	Ambulatory Care (Outpatient Care) 03/2013
1	Injections 05/2004